BioLineRx's CXCR4 Antagonist: Promising For Stem Cell Mobilization And AML

 
• By John Davis
  
AML
• Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D